Urinary Tract Infection
Abstract
In the Clinic6 March 2012Urinary Tract InfectionKalpana Gupta, MD, MPH, Barbara Trautner, MD, PhD, Deborah Cotton, MD, MPH, Darren Taichman, MD, PhD, and Sankey Williams, MDKalpana Gupta, MD, MPH, Barbara Trautner, MD, PhD, Deborah Cotton, MD, MPH, Darren Taichman, MD, PhD, and Sankey Williams, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-156-5-201203060-01003 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail BackgroundWhat patient populations are at greatest risk for UTI?In the absence of known abnormalities of the urinary tract, women are at higher risk for UTIs than are men. Premenopausal adult women are at especially high risk for acute cystitis; incidence is 0.5 to 0.7 per person-year among sexually active women (1). Other populations at risk for UTI include patients with voiding abnormalities related to diabetes, neurogenic bladder, spinal cord injury, pregnancy, prostatic hypertrophy, or urinary tract instrumentation. Bacteriuria, with or without accompanying symptoms, is generally considered unavoidable in patients requiring long-term indwelling catheters.What lifestyle factors or comorbid conditions ...References1. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335:468-74. [PMID:8672152] Google Scholar2. Scholes D, Hooton TM,…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.